An Insight Into the Anxiolytic Effects of Lignans (Phyllanthin and Hypophyllanthin) and Tannin (Corilagin) Rich Extracts of Phyllanthus amarus : An In-Silico and In-vivo approaches
- 1 March 2021
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 24 (3) , 415-422
Abstract
: The extracts and the compounds isolated from Phyllanthus amarus Schumm and Thonn (Family: Euphorbiaceae) have shown a wide spectrum of pharmacological activities including antiviral, antibacterial, antiplasmodial, antimalarial, antimicrobial, anticancer, antidiabetic, hypolipidemic, antioxidant, hepatoprotective, nephroprotective and diurectic properties. Background: This investigation was aimed at exploring the anxiolytic potential of Phyllanthus amarus standardized extracts and predict probable role of marker phyto constitutents. Objective and Methods: Three standardized extracts of Phyllanthus amarus plant viz. standardized aqueous extract of Phyllanthus amarus whole plant (PAAE), standardized methanolic extract of P. amarus leaf (PAME) and the standardized hydro-methanolic extract of P. amarus leaf (PAHME) were tested in the classical animal models of anxiety: Elevated plus-maze model and Light & Dark Exploration test. Results: The lower doses of the tannin rich extract (PAHME) of the P. amarus possess significant anxiolytic activity compared to lignin rich (PAME) and aqueous extracts (PAAE), while at a higher dose (400mg/kg) the results of all three extracts appears to be potentially sedative. While the molecular docking studies support these probable anxiolytic, the sedative effects of the Phyllanthus amarus extracts could be due to the interaction of tannins and lignans with the GABAbenzodiazepine receptor complex. Conclusion: The results of the present study indicate that the tannin-rich extract of the P. amarus may have potential clinical applications in the management of anxiety. It can be further studied for optimum dosage to be used as a future of anti-anxiety drug development or as a standardized Phytomedicine.Keywords
This publication has 40 references indexed in Scilit:
- Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of agingNeuroscience & Biobehavioral Reviews, 2013
- Anti-arthritic activity of standardised extract of Phyllanthus amarus in Freund's complete adjuvant induced arthritisBiomedicine & Aging Pathology, 2011
- Antioxidant potential of aqueous extract of Phyllanthus amarus in ratsIndian Journal of Pharmacology, 2009
- Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarusEuropean Journal of Pharmacology, 2006
- Antimicrobial potentiality ofPhyllanthus amarusagainst drug resistant pathogensNatural Product Research, 2006
- Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in micePhytomedicine, 2005
- Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivoAntiviral Research, 2004
- EFFECT OF PHYLLANTHUS AMARUS ON CHRONIC CARRIERS OF HEPATITIS B VIRUSThe Lancet, 1988
- Some factors influencing conditioned and spontaneous behavior of rats in the light-dark box testPhysiology & Behavior, 1986
- Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the ratJournal of Neuroscience Methods, 1985